28.74
+0.61
+(2.17%)
As of 9:38:40 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,810,000
5,810,000
5,549,000
5,215,000
5,212,000
Cost of Revenue
1,764,000
1,764,000
1,730,000
1,540,000
1,543,000
Gross Profit
4,046,000
4,046,000
3,819,000
3,675,000
3,669,000
Operating Expense
3,186,000
3,186,000
3,199,000
3,041,000
2,987,000
Operating Income
860,000
860,000
620,000
634,000
682,000
Net Non Operating Interest Income Expense
-149,000
-149,000
-105,000
-74,000
-91,000
Pretax Income
498,000
498,000
290,000
235,000
586,000
Tax Provision
86,000
86,000
27,000
12,000
62,000
Net Income Common Stockholders
412,000
412,000
263,000
223,000
524,000
Diluted NI Available to Com Stockholders
412,000
412,000
263,000
223,000
524,000
Basic EPS
0.70
0.94
0.60
0.51
1.20
Diluted EPS
0.70
0.94
0.60
0.51
1.19
Basic Average Shares
435,593.24
436,440.68
435,500
436,000
438,127.09
Diluted Average Shares
436,593.24
438,297.87
436,500
436,500
438,860.97
Total Operating Income as Reported
657,000
657,000
425,000
450,000
593,000
Total Expenses
4,950,000
4,950,000
4,929,000
4,581,000
4,530,000
Net Income from Continuing & Discontinued Operation
412,000
412,000
263,000
223,000
524,000
Normalized Income
579,943.78
579,943.78
439,844.83
397,604.26
536,518.77
Interest Income
24,000
24,000
34,000
14,000
6,000
Interest Expense
168,000
168,000
139,000
91,000
93,000
Net Interest Income
-149,000
-149,000
-105,000
-74,000
-91,000
EBIT
666,000
666,000
429,000
326,000
679,000
EBITDA
1,221,000
1,221,000
956,000
874,000
1,242,000
Reconciled Cost of Revenue
1,764,000
1,764,000
1,730,000
1,540,000
1,543,000
Reconciled Depreciation
555,000
555,000
527,000
548,000
563,000
Net Income from Continuing Operation Net Minority Interest
412,000
412,000
263,000
223,000
524,000
Total Unusual Items Excluding Goodwill
-203,000
-203,000
-195,000
-184,000
-14,000
Total Unusual Items
-203,000
-203,000
-195,000
-184,000
-14,000
Normalized EBITDA
1,424,000
1,424,000
1,151,000
1,058,000
1,256,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-35,056.22
-35,056.22
-18,155.17
-9,395.74
-1,481.23
12/31/2021 - 11/16/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNMD CONMED Corporation
58.66
-2.94%
OFIX Orthofix Medical Inc.
15.90
-2.45%
IART Integra LifeSciences Holdings Corporation
21.30
-2.20%
PHG Koninklijke Philips N.V.
24.68
-0.64%
STE STERIS plc
226.71
-0.38%
FNA Paragon 28, Inc.
13.07
-0.11%
ZBH Zimmer Biomet Holdings, Inc.
111.52
-0.88%
HAE Haemonetics Corporation
62.77
-1.98%
GMED Globus Medical, Inc.
73.07
-3.22%
INSP Inspire Medical Systems, Inc.
154.72
-3.03%